Drugs / bivalent oral poliovirus vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02412514 Comparator | Apr → Dec 2015 | poliomyelitis | Centers for Disease Control and Prevention | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bivalent oral poliovirus vaccine | “receiving inactivated poliovirus vaccine (IPV) and two or three doses of bivalent oral poliovirus vaccine (bOPV).” NCT02412514 ↗ |
| Known as | bOPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02412514 ↗ |
| Modality | Vaccine | “Oral polio vaccines are live attenuated vaccines” NCT02412514 ↗ |
| Route | Oral | “Oral polio vaccines are live attenuated vaccines” NCT02412514 ↗ |